Syphilis
Overview
Syphilis is a systemic infection caused by the spirochaete *Treponema pallidum*, progressing through distinct stages if untreated. Notifiable disease with rising UK incidence, particularly in MSM.
Presentation
•Primary - single, painless, indurated ulcer (chancre) at inoculation site + non-tender regional lymphadenopathy; heals spontaneously in 3-6 weeks
•Secondary - generalised symmetrical non-itchy maculopapular rash classically involving palms and soles; generalised lymphadenopathy, condylomata lata, mucous patches, 'moth-eaten' alopecia, malaise, fever
•Latent - asymptomatic; positive serology only. Early latent <2 years (infectious); late latent >2 years
•Tertiary - occurs in ~1/3 untreated patients; gummatous disease, cardiovascular syphilis, or neurosyphilis
•Cardiovascular syphilis - endarteritis of vasa vasorum → aortitis of ascending aorta → proximal aortic aneurysm, aortic regurgitation, coronary ostial stenosis; 'tree-bark' aortic calcification on imaging
•Neurosyphilis - meningitis (early), meningovascular (stroke-like), tabes dorsalis (lightning pains, ataxia, loss of proprioception, Charcot joints), general paresis (dementia, seizures); Argyll Robertson pupil is pathognomonic
•Congenital syphilis - early (<2 years): rhinitis ('snuffles'), maculopapular rash, hepatosplenomegaly, osteitis. Late (>2 years): Hutchinson's triad - interstitial keratitis, sensorineural deafness, Hutchinson's teeth (notched peg-shaped incisors); saddle-nose deformity, sabre tibia
Investigations
•Dark-field microscopy of chancre exudate - direct visualisation of spirochaetes; highly specific; first-line for primary lesions
•Non-treponemal tests (VDRL/RPR) - screening and monitoring treatment response (titres fall with successful treatment); false positives in pregnancy, SLE, viral infections, antiphospholipid syndrome
•Treponemal tests (TPHA/TPPA/FTA-ABS/EIA) - confirm positive NTT; remain positive for life even after treatment, so cannot monitor response
•Lumbar puncture - required if neurosyphilis suspected; CSF white cells, protein, and VDRL
•Echocardiogram/CT aorta - if cardiovascular syphilis suspected
•HIV serology and full STI screen - all patients
Management
•First-line (primary, secondary, early latent): benzathine penicillin G 2.4 million units IM single dose
•First-line (late latent >2 years or unknown, non-neurological tertiary): benzathine penicillin G 2.4 million units IM weekly for 3 doses
•First-line (neurosyphilis): IV benzylpenicillin for 10-14 days (benzathine penicillin does not reliably penetrate CSF)
•Second-line (penicillin allergy, early syphilis): doxycycline 100 mg orally twice daily for 14 days - NOT suitable in pregnancy
•Second-line (penicillin allergy, late latent): doxycycline 100 mg orally twice daily for 28 days
•Second-line (penicillin allergy, neurosyphilis): ceftriaxone; desensitisation to penicillin preferred in pregnancy
Follow-up
•Monitor treatment response with non-treponemal tests (RPR/VDRL) - fourfold or greater fall in titre at 3-6 months confirms adequate treatment
•Treponemal tests remain positive for life - cannot be used to monitor response
•Contact tracing mandatory; syphilis is a notifiable disease under the Health Protection (Notification) Regulations 2010
Jarisch-Herxheimer Reaction
•Occurs in up to 70% treated for early syphilis, within 2-8 hours of first antibiotic dose
•Caused by massive treponemal antigen release triggering cytokine storm
•Features: fever, rigors, flushing, headache, myalgia, transient worsening of rash - self-limiting within 24 hours
•Management: reassurance, paracetamol, adequate hydration - do NOT stop treatment